NEW! If you don't understand one of the words in this article,
just double-click it.
A window will open with a definition from CancerWEB's On-line Medical Dictionary. If the double-click feature
doesn't work in your browser, you can enter the word below:
Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.
December 8, 2005
FDA Fast-Tracks Hep C Protease Inhibitor
by Staff
December 8, 2005—The U.S. Food and Drug Administration has fast-tracked the first protease inhibitor (PI) to treat the hepatitis C virus, which affects at least one-third of people living with HIV. If proved safe and effective, VX-950, as the PI is now known, will be hurried through clinical trials. In a Phase Ib trial, the drug reduced hep C significantly—on its own, with no other drugs taken.